Better late than never is especially true when it comes to Novavax's highly effective Covid-19 shot https://t.co/YPJeIxjQP6 via @bopinion $nvax

— MASi (@TOWiU2) June 14, 2021

プレスリリースですが、米国で行われている治験で、ノババックスのワクチンが症状がある感染を90.4%予防したようです。

既に米国では他社のワクチンで最初の接種は供給できるので、ノババックスはブースターとして使われる可能性があるようです。https://t.co/fdg4anboOvhttps://t.co/HoKuueRzNq

— 安川康介@米国内科専門医 (@kosuke_yasukawa) June 14, 2021

◆新たに
・米製薬NOVAVAXがコロナワクチンの治験結果を公表
・3万人近くの治験で90%強の有効性
・重度の症状は100%予防
・Pfizer/BioNTechやModernaと同等。J&Jを上回る効果
・2回接種型
・認可されれば世界のワクチン供給に追い風

▽NY Timeshttps://t.co/L0vdxLGVzf

— 後藤達也（日本経済新聞） (@goto_nikkei) June 14, 2021

Novavax’s big US-Mexico trial confirmed their protein vaccine works well, with 90 percent efficacy. It’s late for the US, but not for the world. And it might prove a good booster too. Here is my story for @nytimes https://t.co/YGvfB5QZd7

— Carl Zimmer (@carlzimmer) June 14, 2021

5) The other NYT piece even points out this about Novavax and variants: https://t.co/IctKxmjSGH pic.twitter.com/TKx3U8TAVf

— Eric Feigl-Ding (@DrEricDing) June 14, 2021

Might be a good idea to make the Novavax product available here in USA as an alternative to the genetic vaccines (mRNA, rAdV)https://t.co/T6H9pL7o1P

— Robert W Malone, MD (@RWMaloneMD) June 14, 2021

Novavax was one of Operation Warp Speed’s riskiest bets and it has paid off. It is not acknowledged enough that OWS investments have increased vaccine supply for the entire world. https://t.co/ZuIp3Ez9Xa

— Alex Tabarrok (@ATabarrok) June 14, 2021

The world needs all the vaccines we can get. The Novavax announcement today is very encouraging—remarkably high efficacy, including against variants of concern, with no safety concerns detected in clinical trials of nearly 30,000 people. https://t.co/BnaRN7cDY9

— Dr. Tom Frieden (@DrTomFrieden) June 14, 2021

This is a vaccine that the technology is really exciting. In spite of a small trial in South Africa, the results show a very good signal against the Beta variant! Fantastic to see a small 'start up' company produce such results, inspiring! https://t.co/tSVqK4NYnd

— Tulio de Oliveira (@Tuliodna) June 14, 2021

NEWS: Novavax!

In the 29,960-person trial, the vaccine demonstrated an overall efficacy of 90.4%. This is on par with the vaccines made by Pfizer/BioNTech and Moderna, and higher than the one-shot vaccine from Johnson & Johnson...

By @CarlZimmer ? 1/https://t.co/orVDIEaORb

— Chad P. Bown (@ChadBown) June 14, 2021

Hey! Novavax Offers U.S. a Fourth Strong Covid-19 Vaccine https://t.co/sl9f0XLhDB

— Lyz Lenz (@lyzl) June 14, 2021

Good news of the day! We have another vaccine by Novavax which has shown excellent effectiveness in clinical trials ! Vaccine will be manufactured in India as well. https://t.co/SgGgyJNMOI

— Prabhdeep Kaur (@kprabhdeep) June 14, 2021

Novavax announced that its Covid-19 vaccine showed 90 percent efficacy against the disease.

It uses a new technology, with a little help from some moths. https://t.co/aIqhRMeHXv

— Vox (@voxdotcom) June 14, 2021

What the Novavax vaccine means for the global fight against Covid-19 https://t.co/UQS4qPSfuQ via @voxdotcom
Coming our way in the next few months.

— Professor Adrian Esterman FACE (@profesterman) June 14, 2021

What the Novavax vaccine means for the global fight against Covid-19 https://t.co/HL18e7qF0g

— #TuckFrump (@realTuckFrumper) June 14, 2021

What the Novavax vaccine means for the global fight against Covid-19 https://t.co/4MYrRYvi5s

— Jeffrey Levin (@jilevin) June 14, 2021

Novavax hopes to ramp up its vaccine production to 150 million doses per month by the end of the year. With the virus heavily plaguing other countries, another vaccine will bolster global efforts to defeat the pandemic. https://t.co/6uzjOVplWF

— Vox (@voxdotcom) June 14, 2021